Lupus Drug Benlysta Gets Thumbs Up From FDA Advisory Panel
11/21/2010
For the first time in more than 50 years we might have a drug specially designed to treat lupus approved by the regulatory bodies.
A FDA Arthritis Advisory Committee voted 13 to 2 in favor of approving Benlysta (belimumab), a lupus medication. Now we await the final ruling by FDA and then comes the outcome of the approval process in Europe.
See the press release from GSK here http://www.gsk.com/media/pressreleases/2010/2010_us_pressrelease_10098.htm
Related links:
http://www.lupus.org/newsite/pages/FDA-panel-recommends-approval-of-benlysta-for-lupus.htm
http://lupus.webmd.com/news/20101114/benlysta-shows-promise-for-lupus